Injectable hyaluronic acid for the correction of HIV-associated facial lipoatrophy

Otolaryngology - Head and Neck Surgery

Volumn 136, Issue 4, 2007, Pages 563-567

  Denton, Andrew B ^a   Tsaparas, Yotis ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN IMPLANT; HYALURONIC ACID; PERLANE; RNA DIRECTED DNA POLYMERASE INHIBITOR; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL OBSERVATION; EARLY DIAGNOSIS; ECCHYMOSIS; ERYTHEMA; EVALUATION; FACE DYSMORPHIA; FOLLOW UP; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; HYPERSENSITIVITY; INJECTION PAIN; LIPOATROPHY; MALE; PATIENT SATISFACTION; PHOTOGRAPHY; PROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE; TELANGIECTASIA;

ADULT; FACIAL HEMIATROPHY; HIV INFECTIONS; HIV-ASSOCIATED LIPODYSTROPHY SYNDROME; HUMANS; HYALURONIC ACID; INJECTIONS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 34047136500     PISSN: 01945998     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.otohns.2006.11.049     Document Type: Article

References (19)

1. Talmor M., Hoffman L.A., and LaTrenta G.S. Facial atrophy in HIV-related fat redistribution syndrome: anatomic evaluation and surgical reconstruction. Ann Plast Surg 49 1 (2002) 11-17
2. Collins E., Wagner C., and Walmsley S. Psychosocial impact of the lipodystrophy syndrome in HIV infection. AIDS Reader 10 (2000) 546-551
3. Carr A., Samaras K., Chrisholm D.J., et al. Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidemia and insulin resistance. Lancet 354 (1999) 1112-1115
4. Mallal S.A., John M., Moore C.B., et al. Contribution of nucleoside analogue reverse transcriptase inhibitors to subcutaneous fat wasting in patients with HIV infection. AIDS 14 (2000) 1309-1316
5. Oral E.A., Simha V., Ruiz E., et al. Leptin-replacement therapy for lipodystrophy. N Eng J Med 346 (2002) 570-578
6. Upton J., Albin R.E., Mulliken J.B., et al. The use of scapular and parascapular flaps for cheek reconstruction. Plast Recon Surg 90 6 (1992) 959-971
7. Endo T., Nakayama Y., Natsui H., et al. Facial contour reconstruction in lipodystrophy using a double paddle dermis-fat radial forearm free flap. Ann Plast Surg 32 1 (1994) 93-96
8. Longaker M.T., Flynn A., and Siebert J.W. Microsurgical correction of bilateral facial contour deformities. Plast Recon Surg 98 6 (1996) 951-957
9. Orentreich D., and Leone A.S. A case of HIV-associated facial lipoatrophy treated with 1000-cs liquid injectable silicone. Dermatol Surg 30 4 PT 1 (2004) 548-551
10. James J., Carruthers A., and Carruthers J. HIV-associated facial lipoatrophy. Dermatol Surg 28 11 (2002) 979-986
11. DeLustro F., Mackinno V., and Swanson N.A. Immunology of injectable collagen in human subjects. J Dermatol Surg Oncol 14 supl 1 (1988) 49-55
12. Friedman P.M., Mafong E.A., and Kauvar A.N.B. Safety data of injectable nonanimal stabilized hyaluronic acid gel for soft tissue augmentation. Dermatol Surg 28 6 (2002) 491-494
13. Shore J.W. Injectable lyophilized particulate human fascia (Fascian) for lip, perioral, and glabellar enhancement. Ophthalmic Plast Reconstr Surg 16 (1999) 23-27
14. Burres S. Preserved particulate fascia lata for injection: a new alternative. Dermatol Surg 25 (1999) 790-794
15. Burres S. Soft tissue augmentation with Fascian. Clin Plast Surg 1 (2001) 101-110
16. Homicz M.R., and Watson D. Review of injectable materials for soft tissue augmentation. Fac Plast Surg 20 1 (2004) 21-29
17. Moyle G.J., Lysakova L., Brown A., et al. A randomized open-label study of immediate versus delayed polylactic acid injections for the cosmetic management of facial lipoatrophy in persons with HIV infection. HIV Medicine 5 2 (2004) 82-87
18. Valantin M.A., Aubron-Oliver C., Katlama C., et al. Polylactic acid implants (New-Fill) to correct facial lipoatrophy in HIV-infected patients: results of the open-label study VEGA. AIDS 17 17 (2003) 2471-2477
19. Blanch J., Rousaud A., Batell J.M., et al. Impact of lipodystrophy on the quality of life of HIV-1 infected patients. J AIDS 31 4 (2002) 404-407